Filing Details

Accession Number:
0001209191-20-048974
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-01 19:02:05
Reporting Period:
2020-08-31
Accepted Time:
2020-09-01 19:02:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1097149 Align Technology Inc ALGN Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 943267295
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1215490 Joseph Lacob C/o Align Technology Inc.
2820 Orchard Parkway
San Jose CA 95131
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-31 2,190 $298.71 162,170 No 4 S Indirect By Trust
Common Stock Disposition 2020-08-31 3,085 $300.32 159,085 No 4 S Indirect By Trust
Common Stock Disposition 2020-08-31 5,000 $300.00 154,085 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
Footnotes
  1. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $298.46 to $298.93, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The shares are held directly by a trust for which the reporting person is the trustee.
  3. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.86, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.